Cargando…
Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells
To date, malignant pheochromocytomas and paragangliomas (PHEOs/PGLs) cannot be effectively cured and thus novel treatment strategies are urgently needed. Lovastatin has been shown to effectively induce apoptosis in mouse PHEO cells (MPC) and the more aggressive mouse tumor tissue-derived cells (MTT)...
Autores principales: | Fliedner, Stephanie M. J., Engel, Tobias, Lendvai, Nikoletta K., Shankavaram, Uma, Nölting, Svenja, Wesley, Robert, Elkahloun, Abdel G., Ungefroren, Hendrik, Oldoerp, Angela, Lampert, Gary, Lehnert, Hendrik, Timmers, Henri, Pacak, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028222/ https://www.ncbi.nlm.nih.gov/pubmed/24846270 http://dx.doi.org/10.1371/journal.pone.0097712 |
Ejemplares similares
-
Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021) -
High-Throughput Screening for the Identification of New Therapeutic Options for Metastatic Pheochromocytoma and Paraganglioma
por: Giubellino, Alessio, et al.
Publicado: (2014) -
Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster()()
por: Fliedner, Stephanie M.J., et al.
Publicado: (2016) -
Warburg Effect’s Manifestation in Aggressive Pheochromocytomas and Paragangliomas: Insights from a Mouse Cell Model Applied to Human Tumor Tissue
por: Fliedner, Stephanie M. J., et al.
Publicado: (2012) -
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
por: Nölting, Svenja, et al.
Publicado: (2019)